Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (641-650 of 831) with videos related to

Pageof 84
Sort By:
Acta Neuropathologica|January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
Acta Neuropathologica|October 24, 2015
Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Acta Neuropathologica|April 9, 2018
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLeah M Katz, Thomas Hielscher, Benjamin Liechty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaRoger Stupp, Monika E Hegi, Bart Neyns, et al.
Journal of Neuro-Oncology|August 19, 2009
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomideGregor Dresemann, Michael Weller, Mark A Rosenthal, et al.
Neuro-Oncology|April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival periodMarijke B Coomans, Linda Dirven, Neil Aaronson, et al.
Neuro-Oncology|February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposalEmilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.
The New England Journal of Medicine|March 11, 2005
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaRoger Stupp, Warren P Mason, Martin J van den Bent, et al.
Nature Medicine|June 18, 2013
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugsErich Gulbins, Monica Palmada, Martin Reichel, et al.
Pageof 84

Showing results (641-650 of 831) with videos related to

Sort By:
Pageof 84
Acta Neuropathologica|January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
Acta Neuropathologica|October 24, 2015
Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Acta Neuropathologica|April 9, 2018
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLeah M Katz, Thomas Hielscher, Benjamin Liechty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaRoger Stupp, Monika E Hegi, Bart Neyns, et al.
Journal of Neuro-Oncology|August 19, 2009
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomideGregor Dresemann, Michael Weller, Mark A Rosenthal, et al.
Neuro-Oncology|April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival periodMarijke B Coomans, Linda Dirven, Neil Aaronson, et al.
Neuro-Oncology|February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposalEmilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.
The New England Journal of Medicine|March 11, 2005
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaRoger Stupp, Warren P Mason, Martin J van den Bent, et al.
Nature Medicine|June 18, 2013
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugsErich Gulbins, Monica Palmada, Martin Reichel, et al.
Pageof 84